Skip to content

K-V Pharmaceutical Co

Delisted

CIK 57055fmd_0N9Q11VHCKYHSARM4ENHGMFK10Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2009 to Mar 31, 2012, 9 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Total revenues92723
Cost of revenue212
Gross profit82621
Research and development271916
Selling, general and administrative112101114
Total operating expenses313128162
Operating income(305)(102)(141)
Interest expense81639
Interest and investment income625
Other non-operating income (expense)(2)(147)53
Income before taxes(308)(248)(88)
Income tax expense(24)810
Net income from continuing operations(284)(256)(98)
Net income(284)(272)(102)
K-V Pharmaceutical Co financial statements · FinancialMD